NO845169L - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivaterInfo
- Publication number
- NO845169L NO845169L NO845169A NO845169A NO845169L NO 845169 L NO845169 L NO 845169L NO 845169 A NO845169 A NO 845169A NO 845169 A NO845169 A NO 845169A NO 845169 L NO845169 L NO 845169L
- Authority
- NO
- Norway
- Prior art keywords
- group
- general formula
- benzimidazole
- phenyl
- methoxy
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 8
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title claims description 3
- 150000001556 benzimidazoles Chemical class 0.000 title claims description 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- -1 hydroxy- Chemical class 0.000 claims description 115
- 150000001875 compounds Chemical class 0.000 claims description 85
- 239000002253 acid Substances 0.000 claims description 23
- 125000004432 carbon atom Chemical group C* 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 239000011541 reaction mixture Substances 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 7
- 125000004647 alkyl sulfenyl group Chemical group 0.000 claims description 7
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 6
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims description 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 4
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
- 150000004820 halides Chemical class 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 150000003462 sulfoxides Chemical class 0.000 claims description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 4
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 claims description 3
- 125000006598 aminocarbonylamino group Chemical group 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 230000021235 carbamoylation Effects 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000005159 cyanoalkoxy group Chemical group 0.000 claims description 3
- 238000006264 debenzylation reaction Methods 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 125000002071 phenylalkoxy group Chemical group 0.000 claims description 3
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims description 2
- SKJMXFYDJLQRSX-UHFFFAOYSA-N 2-(2-methoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazole-5-carbonitrile Chemical compound COC1=CC(OCC#C)=CC=C1C1=NC2=CC=C(C#N)C=C2N1 SKJMXFYDJLQRSX-UHFFFAOYSA-N 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 claims description 2
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 125000004966 cyanoalkyl group Chemical group 0.000 claims description 2
- 125000004472 dialkylaminosulfonyl group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- JUINSXZKUKVTMD-UHFFFAOYSA-N hydrogen azide Chemical compound N=[N+]=[N-] JUINSXZKUKVTMD-UHFFFAOYSA-N 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 230000000269 nucleophilic effect Effects 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- HOPHVZYQZLXWGE-UHFFFAOYSA-N 2-(2-methoxy-4-methylsulfonylphenyl)-3h-benzimidazole-5-carbonitrile Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1C1=NC2=CC=C(C#N)C=C2N1 HOPHVZYQZLXWGE-UHFFFAOYSA-N 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 44
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 238000002844 melting Methods 0.000 description 25
- 230000008018 melting Effects 0.000 description 25
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 229960000583 acetic acid Drugs 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000012362 glacial acetic acid Substances 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 15
- 229960004756 ethanol Drugs 0.000 description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 238000009835 boiling Methods 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 239000011877 solvent mixture Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- RIZQKJHWYJFKAP-UHFFFAOYSA-N 2-methoxy-4-prop-2-ynoxybenzoic acid Chemical compound COC1=CC(OCC#C)=CC=C1C(O)=O RIZQKJHWYJFKAP-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000009090 positive inotropic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- JFWBWLHAYKHBFG-UHFFFAOYSA-N 2-(2-methoxy-4-methylsulfanylphenyl)-3h-benzimidazole-5-carbonitrile Chemical compound COC1=CC(SC)=CC=C1C1=NC2=CC=C(C#N)C=C2N1 JFWBWLHAYKHBFG-UHFFFAOYSA-N 0.000 description 2
- GXDJZYFPFPEPTE-UHFFFAOYSA-N 2-(2-methoxy-4-methylsulfanylphenyl)-3h-benzimidazole-5-carboxamide Chemical compound COC1=CC(SC)=CC=C1C1=NC2=CC=C(C(N)=O)C=C2N1 GXDJZYFPFPEPTE-UHFFFAOYSA-N 0.000 description 2
- HMCIMXUDLBAPBY-UHFFFAOYSA-N 2-(2-methoxy-4-methylsulfinylphenyl)-3h-benzimidazole-5-carbonitrile Chemical compound COC1=CC(S(C)=O)=CC=C1C1=NC2=CC=C(C#N)C=C2N1 HMCIMXUDLBAPBY-UHFFFAOYSA-N 0.000 description 2
- BDFDUVRCPCOICK-UHFFFAOYSA-N 2-(2-methoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazole-5-carboxylic acid Chemical compound COC1=CC(OCC#C)=CC=C1C1=NC2=CC=C(C(O)=O)C=C2N1 BDFDUVRCPCOICK-UHFFFAOYSA-N 0.000 description 2
- CWMQSSZCYHTFQN-UHFFFAOYSA-N 2-(2-methoxy-4-sulfamoylphenyl)-3h-benzimidazole-5-carboxylic acid Chemical compound COC1=CC(S(N)(=O)=O)=CC=C1C1=NC2=CC=C(C(O)=O)C=C2N1 CWMQSSZCYHTFQN-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- YRTOLUBGMMPKCK-UHFFFAOYSA-N 4-(6-cyano-1h-benzimidazol-2-yl)-3-methoxybenzenesulfonamide Chemical compound COC1=CC(S(N)(=O)=O)=CC=C1C1=NC2=CC=C(C#N)C=C2N1 YRTOLUBGMMPKCK-UHFFFAOYSA-N 0.000 description 2
- GALBBJWFBVIQRH-UHFFFAOYSA-N 6-fluoro-2-(2-methoxy-4-phenylmethoxyphenyl)-1h-benzimidazole Chemical compound C=1C=C(C=2NC3=CC(F)=CC=C3N=2)C(OC)=CC=1OCC1=CC=CC=C1 GALBBJWFBVIQRH-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 125000005336 allyloxy group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- COJOJJDGZHELMI-UHFFFAOYSA-N methyl 2-(2-methoxy-4-sulfamoylphenyl)-3h-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OC)=CC=C2N=C1C1=CC=C(S(N)(=O)=O)C=C1OC COJOJJDGZHELMI-UHFFFAOYSA-N 0.000 description 2
- ULSKIUHUELQDBP-UHFFFAOYSA-N methyl 3,4-diaminobenzoate;dihydrochloride Chemical compound Cl.Cl.COC(=O)C1=CC=C(N)C(N)=C1 ULSKIUHUELQDBP-UHFFFAOYSA-N 0.000 description 2
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- FBAOVPVVMDOHPK-UHFFFAOYSA-N 2-(1h-imidazol-2-ylsulfinyl)-1h-imidazole Chemical compound N=1C=CNC=1S(=O)C1=NC=CN1 FBAOVPVVMDOHPK-UHFFFAOYSA-N 0.000 description 1
- CJGAHEXUZUXIFH-UHFFFAOYSA-N 2-(2-ethoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazole-5-carbonitrile Chemical compound CCOC1=CC(OCC#C)=CC=C1C1=NC2=CC=C(C#N)C=C2N1 CJGAHEXUZUXIFH-UHFFFAOYSA-N 0.000 description 1
- GIBHKTBGAOMYEB-UHFFFAOYSA-N 2-(2-ethoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazole-5-carboxamide Chemical compound CCOC1=CC(OCC#C)=CC=C1C1=NC2=CC=C(C(N)=O)C=C2N1 GIBHKTBGAOMYEB-UHFFFAOYSA-N 0.000 description 1
- JKLJQTBGXIZDAU-UHFFFAOYSA-N 2-(2-ethoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazole-5-carboxylic acid Chemical compound CCOC1=CC(OCC#C)=CC=C1C1=NC2=CC=C(C(O)=O)C=C2N1 JKLJQTBGXIZDAU-UHFFFAOYSA-N 0.000 description 1
- JYZLKOOLPSGHDC-UHFFFAOYSA-N 2-(2-methoxy-4-methylsulfanylphenyl)-3h-benzimidazole-5-carboxylic acid Chemical compound COC1=CC(SC)=CC=C1C1=NC2=CC=C(C(O)=O)C=C2N1 JYZLKOOLPSGHDC-UHFFFAOYSA-N 0.000 description 1
- RLQQZMBJPCOADK-UHFFFAOYSA-N 2-(2-methoxy-4-methylsulfanylphenyl)-n,n-dimethyl-3h-benzimidazole-5-carboxamide Chemical compound COC1=CC(SC)=CC=C1C1=NC2=CC=C(C(=O)N(C)C)C=C2N1 RLQQZMBJPCOADK-UHFFFAOYSA-N 0.000 description 1
- FFJCVLBCONPCHP-UHFFFAOYSA-N 2-(2-methoxy-4-methylsulfanylphenyl)-n-methyl-3h-benzimidazole-5-carboxamide Chemical compound N1C2=CC(C(=O)NC)=CC=C2N=C1C1=CC=C(SC)C=C1OC FFJCVLBCONPCHP-UHFFFAOYSA-N 0.000 description 1
- JTAJUJGSZRXDRA-UHFFFAOYSA-N 2-(2-methoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazol-5-amine Chemical compound COC1=CC(OCC#C)=CC=C1C1=NC2=CC=C(N)C=C2N1 JTAJUJGSZRXDRA-UHFFFAOYSA-N 0.000 description 1
- YLFOGHHMILYVKT-UHFFFAOYSA-N 2-(2-methoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazole-5-carbonyl chloride Chemical compound COC1=CC(OCC#C)=CC=C1C1=NC2=CC=C(C(Cl)=O)C=C2N1 YLFOGHHMILYVKT-UHFFFAOYSA-N 0.000 description 1
- PGFIXPCVPSVUMJ-UHFFFAOYSA-N 2-(2-methoxy-4-prop-2-ynoxyphenyl)-6-nitro-1h-benzimidazole Chemical compound COC1=CC(OCC#C)=CC=C1C1=NC2=CC=C([N+]([O-])=O)C=C2N1 PGFIXPCVPSVUMJ-UHFFFAOYSA-N 0.000 description 1
- PCXSCIXAYUKKQE-UHFFFAOYSA-N 2-(2-methoxy-4-prop-2-ynoxyphenyl)-n-methyl-3h-benzimidazole-5-carboxamide Chemical compound N1C2=CC(C(=O)NC)=CC=C2N=C1C1=CC=C(OCC#C)C=C1OC PCXSCIXAYUKKQE-UHFFFAOYSA-N 0.000 description 1
- KSTPKRFESIZQPA-UHFFFAOYSA-N 2-(2-methoxy-4-sulfamoylphenyl)-3h-benzimidazole-5-carboxamide Chemical compound COC1=CC(S(N)(=O)=O)=CC=C1C1=NC2=CC=C(C(N)=O)C=C2N1 KSTPKRFESIZQPA-UHFFFAOYSA-N 0.000 description 1
- AVQBQWIQWJJVQD-UHFFFAOYSA-N 2-(2-methoxy-4-sulfamoylphenyl)-n-methyl-3h-benzimidazole-5-carboxamide Chemical compound N1C2=CC(C(=O)NC)=CC=C2N=C1C1=CC=C(S(N)(=O)=O)C=C1OC AVQBQWIQWJJVQD-UHFFFAOYSA-N 0.000 description 1
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 1
- XLASRXYDAOGJDW-UHFFFAOYSA-N 2-(4-ethylsulfinyl-2-methoxyphenyl)-3h-benzimidazole-5-carbonitrile Chemical compound COC1=CC(S(=O)CC)=CC=C1C1=NC2=CC=C(C#N)C=C2N1 XLASRXYDAOGJDW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- RUZAHKTXOIYZNE-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid;iron(2+) Chemical compound [Fe+2].OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O RUZAHKTXOIYZNE-UHFFFAOYSA-N 0.000 description 1
- QWCNOAMINKDLSX-UHFFFAOYSA-N 2-[2-methoxy-4-(methylsulfamoyl)phenyl]-3h-benzimidazole-5-carboxamide Chemical compound COC1=CC(S(=O)(=O)NC)=CC=C1C1=NC2=CC=C(C(N)=O)C=C2N1 QWCNOAMINKDLSX-UHFFFAOYSA-N 0.000 description 1
- ZQEZRNCNMJKGJE-UHFFFAOYSA-N 2-[2-methoxy-4-(methylsulfamoyl)phenyl]-3h-benzimidazole-5-carboxylic acid Chemical compound COC1=CC(S(=O)(=O)NC)=CC=C1C1=NC2=CC=C(C(O)=O)C=C2N1 ZQEZRNCNMJKGJE-UHFFFAOYSA-N 0.000 description 1
- XWOAUXVBHKGKBH-UHFFFAOYSA-N 2-[4-(6-fluoro-1h-benzimidazol-2-yl)-3-methoxyphenoxy]acetonitrile Chemical compound COC1=CC(OCC#N)=CC=C1C1=NC2=CC=C(F)C=C2N1 XWOAUXVBHKGKBH-UHFFFAOYSA-N 0.000 description 1
- HHGITXMDHXBOJF-UHFFFAOYSA-N 2-[4-(6-fluoro-1h-benzimidazol-2-yl)-3-methoxyphenyl]sulfanylacetonitrile Chemical compound COC1=CC(SCC#N)=CC=C1C1=NC2=CC=C(F)C=C2N1 HHGITXMDHXBOJF-UHFFFAOYSA-N 0.000 description 1
- RPEYTLDHQDVAKG-UHFFFAOYSA-N 2-[4-(dimethylsulfamoyl)-2-methoxyphenyl]-3h-benzimidazole-5-carboxamide Chemical compound COC1=CC(S(=O)(=O)N(C)C)=CC=C1C1=NC2=CC=C(C(N)=O)C=C2N1 RPEYTLDHQDVAKG-UHFFFAOYSA-N 0.000 description 1
- VOVIRFDTIRKOIQ-UHFFFAOYSA-N 2-[4-(dimethylsulfamoyl)-2-methoxyphenyl]-3h-benzimidazole-5-carboxylic acid Chemical compound COC1=CC(S(=O)(=O)N(C)C)=CC=C1C1=NC2=CC=C(C(O)=O)C=C2N1 VOVIRFDTIRKOIQ-UHFFFAOYSA-N 0.000 description 1
- DWOSBILUUWDRDJ-UHFFFAOYSA-N 2-[4-(dipropylsulfamoyl)-2-methoxyphenyl]-3h-benzimidazole-5-carboxamide Chemical compound COC1=CC(S(=O)(=O)N(CCC)CCC)=CC=C1C1=NC2=CC=C(C(N)=O)C=C2N1 DWOSBILUUWDRDJ-UHFFFAOYSA-N 0.000 description 1
- UOPCPHJGGRTYNC-UHFFFAOYSA-N 2-methoxy-4-methylsulfanylbenzoic acid Chemical compound COC1=CC(SC)=CC=C1C(O)=O UOPCPHJGGRTYNC-UHFFFAOYSA-N 0.000 description 1
- SKQWLDXXQLJSHA-UHFFFAOYSA-N 2-methoxy-4-phenylmethoxybenzoic acid Chemical compound C1=C(C(O)=O)C(OC)=CC(OCC=2C=CC=CC=2)=C1 SKQWLDXXQLJSHA-UHFFFAOYSA-N 0.000 description 1
- CSDXOGPIGCMWCZ-UHFFFAOYSA-N 2-methoxy-4-sulfamoylbenzoic acid Chemical compound COC1=CC(S(N)(=O)=O)=CC=C1C(O)=O CSDXOGPIGCMWCZ-UHFFFAOYSA-N 0.000 description 1
- JISLMPYAPISBPX-UHFFFAOYSA-N 2-methoxy-4-sulfamoylbenzoyl chloride Chemical compound COC1=CC(S(N)(=O)=O)=CC=C1C(Cl)=O JISLMPYAPISBPX-UHFFFAOYSA-N 0.000 description 1
- VWLLPPSBBHDXHK-UHFFFAOYSA-N 3,4-diaminobenzonitrile Chemical compound NC1=CC=C(C#N)C=C1N VWLLPPSBBHDXHK-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PLDNKLXKIGUZRI-UHFFFAOYSA-N 4-(6-cyano-1h-benzimidazol-2-yl)-3-methoxy-n,n-dipropylbenzenesulfonamide Chemical compound COC1=CC(S(=O)(=O)N(CCC)CCC)=CC=C1C1=NC2=CC=C(C#N)C=C2N1 PLDNKLXKIGUZRI-UHFFFAOYSA-N 0.000 description 1
- BTMALOCIFAITOV-UHFFFAOYSA-N 4-(6-fluoro-1H-benzimidazol-2-yl)-3-methoxyphenol Chemical compound COC1=CC(O)=CC=C1C1=NC2=CC=C(F)C=C2N1 BTMALOCIFAITOV-UHFFFAOYSA-N 0.000 description 1
- JAHADAZIDZMHOP-UHFFFAOYSA-N 4-amino-3-nitrobenzonitrile Chemical compound NC1=CC=C(C#N)C=C1[N+]([O-])=O JAHADAZIDZMHOP-UHFFFAOYSA-N 0.000 description 1
- KWEWNOOZQVJONF-UHFFFAOYSA-N 4-fluorobenzene-1,2-diamine Chemical compound NC1=CC=C(F)C=C1N KWEWNOOZQVJONF-UHFFFAOYSA-N 0.000 description 1
- RAUWPNXIALNKQM-UHFFFAOYSA-N 4-nitro-1,2-phenylenediamine Chemical compound NC1=CC=C([N+]([O-])=O)C=C1N RAUWPNXIALNKQM-UHFFFAOYSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- RZKAVVYSYFPMEG-UHFFFAOYSA-N C(C)OC1=C(C=CC(=C1)SC)C=1NC2=C(N=1)C=CC(=C2)C#N.COC1=C(C=CC(=C1)SCCC)C=1NC2=C(N=1)C=CC(=C2)C#N.COC1=C(C=CC(=C1)SCC)C=1NC2=C(N=1)C=CC(=C2)C#N Chemical compound C(C)OC1=C(C=CC(=C1)SC)C=1NC2=C(N=1)C=CC(=C2)C#N.COC1=C(C=CC(=C1)SCCC)C=1NC2=C(N=1)C=CC(=C2)C#N.COC1=C(C=CC(=C1)SCC)C=1NC2=C(N=1)C=CC(=C2)C#N RZKAVVYSYFPMEG-UHFFFAOYSA-N 0.000 description 1
- YPJIAJSRWSZJFM-UHFFFAOYSA-N COC1=C(C=CC(=C1)S(=O)(=O)N)C=1NC2=C(N1)C=CC(=C2)C(=O)N(CCC)CCC Chemical compound COC1=C(C=CC(=C1)S(=O)(=O)N)C=1NC2=C(N1)C=CC(=C2)C(=O)N(CCC)CCC YPJIAJSRWSZJFM-UHFFFAOYSA-N 0.000 description 1
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 1
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CUTCGOYYKAMFCS-UHFFFAOYSA-N N1C2=CC(NC(=O)NC)=CC=C2N=C1C1=CC=C(OCC#C)C=C1OC Chemical compound N1C2=CC(NC(=O)NC)=CC=C2N=C1C1=CC=C(OCC#C)C=C1OC CUTCGOYYKAMFCS-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GHVZOJONCUEWAV-UHFFFAOYSA-N [K].CCO Chemical compound [K].CCO GHVZOJONCUEWAV-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005122 aminoalkylamino group Chemical group 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 229940076134 benzene Drugs 0.000 description 1
- LTQXVMLZHLJHIN-UHFFFAOYSA-N benzimidazol-2-ylidenemethanone Chemical compound C1=CC=CC2=NC(=C=O)N=C21 LTQXVMLZHLJHIN-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 1
- GNVMUORYQLCPJZ-UHFFFAOYSA-N carbamothioic s-acid Chemical class NC(S)=O GNVMUORYQLCPJZ-UHFFFAOYSA-N 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000007928 imidazolide derivatives Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- IKTADLXVAWZYQH-UHFFFAOYSA-N methyl 2-(2-ethoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazole-5-carboxylate Chemical compound CCOC1=CC(OCC#C)=CC=C1C1=NC2=CC=C(C(=O)OC)C=C2N1 IKTADLXVAWZYQH-UHFFFAOYSA-N 0.000 description 1
- LBQJWRXEQJIIII-UHFFFAOYSA-N methyl 2-(2-ethoxy-4-propylsulfanylphenyl)-3h-benzimidazole-5-carboxylate Chemical compound CCOC1=CC(SCCC)=CC=C1C1=NC2=CC=C(C(=O)OC)C=C2N1 LBQJWRXEQJIIII-UHFFFAOYSA-N 0.000 description 1
- KOJOPBLYMUNWAP-UHFFFAOYSA-N methyl 2-(2-methoxy-4-methylsulfanylphenyl)-3h-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OC)=CC=C2N=C1C1=CC=C(SC)C=C1OC KOJOPBLYMUNWAP-UHFFFAOYSA-N 0.000 description 1
- MWDRCFMBSXUODJ-UHFFFAOYSA-N methyl 2-(2-methoxy-4-prop-2-ynoxyphenyl)-3h-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OC)=CC=C2N=C1C1=CC=C(OCC#C)C=C1OC MWDRCFMBSXUODJ-UHFFFAOYSA-N 0.000 description 1
- WQKSSERGHCNFIL-UHFFFAOYSA-N methyl 2-[2-methoxy-4-(methylsulfamoyl)phenyl]-3h-benzimidazole-5-carboxylate Chemical compound COC1=CC(S(=O)(=O)NC)=CC=C1C1=NC2=CC=C(C(=O)OC)C=C2N1 WQKSSERGHCNFIL-UHFFFAOYSA-N 0.000 description 1
- OQCYBPONLOWFQI-UHFFFAOYSA-N methyl 2-[4-(dimethylsulfamoyl)-2-methoxyphenyl]-3h-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OC)=CC=C2N=C1C1=CC=C(S(=O)(=O)N(C)C)C=C1OC OQCYBPONLOWFQI-UHFFFAOYSA-N 0.000 description 1
- ZUKAXVAMLWQMQN-UHFFFAOYSA-N methyl 2-[4-(dipropylsulfamoyl)-2-ethoxyphenyl]-3h-benzimidazole-5-carboxylate Chemical compound CCOC1=CC(S(=O)(=O)N(CCC)CCC)=CC=C1C1=NC2=CC=C(C(=O)OC)C=C2N1 ZUKAXVAMLWQMQN-UHFFFAOYSA-N 0.000 description 1
- IOPLHGOSNCJOOO-UHFFFAOYSA-N methyl 3,4-diaminobenzoate Chemical compound COC(=O)C1=CC=C(N)C(N)=C1 IOPLHGOSNCJOOO-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000500 noncardiotoxic Toxicity 0.000 description 1
- 150000007530 organic bases Chemical group 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Inorganic materials [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- WJUFNBHSODTIHU-UHFFFAOYSA-N propyl 2-(2-methoxy-4-methylsulfanylphenyl)-3h-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OCCC)=CC=C2N=C1C1=CC=C(SC)C=C1OC WJUFNBHSODTIHU-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- UNHKSXOTUHOTAB-UHFFFAOYSA-N sodium;sulfane Chemical compound [Na].S UNHKSXOTUHOTAB-UHFFFAOYSA-N 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003450 sulfenic acids Chemical class 0.000 description 1
- 150000003455 sulfinic acids Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3346575A DE3346575A1 (de) | 1983-12-23 | 1983-12-23 | Neue benzimidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO845169L true NO845169L (no) | 1985-06-24 |
Family
ID=6217793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO845169A NO845169L (no) | 1983-12-23 | 1984-12-21 | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0148431A1 (ja) |
| JP (1) | JPS60156676A (ja) |
| KR (1) | KR850004467A (ja) |
| AU (1) | AU3704284A (ja) |
| DD (1) | DD232697A5 (ja) |
| DE (1) | DE3346575A1 (ja) |
| DK (1) | DK597484A (ja) |
| ES (5) | ES538929A0 (ja) |
| FI (1) | FI845084L (ja) |
| HU (1) | HU193073B (ja) |
| IL (1) | IL73897A0 (ja) |
| NO (1) | NO845169L (ja) |
| PT (1) | PT79718B (ja) |
| ZA (1) | ZA849972B (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU85544A1 (fr) * | 1984-09-19 | 1986-04-03 | Cird | Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique |
| DE3522230A1 (de) * | 1985-06-21 | 1987-01-02 | Thomae Gmbh Dr K | Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| FR2677020B1 (fr) * | 1991-05-31 | 1993-08-27 | Cird Galderma | Composes derives de benzimidazole, leur procede de preparation et leur utilisation dans les domaines therapeutique et cosmetique. |
| US5821258A (en) * | 1994-12-27 | 1998-10-13 | Mitsui Chemicals, Inc. | Phenylbenzimidazole derivatives |
| NZ313713A (en) * | 1995-08-02 | 2001-03-30 | Univ Newcastle Ventures Ltd | Benzimidazole-4-carboxamide derivatives useful as poly(ADP-ribose)polymerase or PARP enzyme inhibitors |
| US5942532A (en) * | 1997-09-05 | 1999-08-24 | Ortho Pharmaceutical Corporation | 2-substituted phenyl-benzimidazole antibacterial agents |
| US7271261B2 (en) | 2001-10-19 | 2007-09-18 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted benzimidazoles and imidazo-[4,5]-pyridines |
| JP2006513159A (ja) * | 2002-11-01 | 2006-04-20 | メルク エンド カムパニー インコーポレーテッド | アンドロゲン受容体モジュレーターとしてのカルボニルアミノ−ベンズイミダゾール誘導体 |
| ATE363905T1 (de) | 2003-04-17 | 2007-06-15 | Janssen Pharmaceutica Nv | 2-phenyl-benzimidazol und 2-phenyl-imidazo-4,5)- pyridin-derivate als checkpoint-kinase-cds1 (chk2)-hemmer zur behandlung von krebs |
| CA2572218C (en) | 2004-06-30 | 2013-06-11 | Janssen Pharmaceutica, N.V. | Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| WO2012086848A1 (en) | 2010-12-24 | 2012-06-28 | Sumitomo Chemical Company, Limited | Fused heterocyclic compound and use for pest control thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH350763A (de) * | 1958-10-14 | 1960-12-15 | Ciba Geigy | Verwendung von Azolverbindungen als Schutzmittel gegen ultraviolette Strahlung |
| DE1447733B2 (de) * | 1963-12-23 | 1977-04-21 | Hoechst Ag, 6000 Frankfurt | 2-(3,5-dihydroxyphenyl)-benzimidazolderivate |
| IL23847A (en) * | 1964-08-07 | 1969-02-27 | Merck & Co Inc | Benzimidazoles useful as antifungals |
| FR1569337A (ja) * | 1968-06-18 | 1969-05-30 | ||
| DE2742093A1 (de) * | 1977-09-19 | 1979-03-29 | Cassella Ag | Verfahren zur herstellung von 2-(3'- bzw. 4'-aminophenyl)-5(bzw. 6) -aminobenzimidazolen |
| DE2927987A1 (de) * | 1979-07-11 | 1981-02-05 | Thomae Gmbh Dr K | Neue 2-alkoxyphenyl-imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine, deren herstellung und deren verwendung als arzneimittel |
| DE3224512A1 (de) * | 1982-07-01 | 1984-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
-
1983
- 1983-12-23 DE DE3346575A patent/DE3346575A1/de not_active Withdrawn
-
1984
- 1984-12-08 EP EP84114999A patent/EP0148431A1/de not_active Withdrawn
- 1984-12-13 DK DK597484A patent/DK597484A/da not_active Application Discontinuation
- 1984-12-20 PT PT79718A patent/PT79718B/pt unknown
- 1984-12-20 JP JP59269563A patent/JPS60156676A/ja active Pending
- 1984-12-21 FI FI845084A patent/FI845084L/fi not_active Application Discontinuation
- 1984-12-21 NO NO845169A patent/NO845169L/no unknown
- 1984-12-21 HU HU844808A patent/HU193073B/hu unknown
- 1984-12-21 KR KR1019840008220A patent/KR850004467A/ko not_active Application Discontinuation
- 1984-12-21 DD DD84271449A patent/DD232697A5/de unknown
- 1984-12-21 AU AU37042/84A patent/AU3704284A/en not_active Abandoned
- 1984-12-21 ZA ZA849972A patent/ZA849972B/xx unknown
- 1984-12-21 ES ES538929A patent/ES538929A0/es active Granted
- 1984-12-21 IL IL73897A patent/IL73897A0/xx unknown
-
1985
- 1985-06-13 ES ES544116A patent/ES8604162A1/es not_active Expired
- 1985-06-13 ES ES544117A patent/ES8604163A1/es not_active Expired
- 1985-06-13 ES ES544119A patent/ES8604165A1/es not_active Expired
- 1985-06-13 ES ES544118A patent/ES8604164A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK597484A (da) | 1985-06-24 |
| PT79718A (de) | 1985-01-01 |
| PT79718B (de) | 1986-12-30 |
| KR850004467A (ko) | 1985-07-15 |
| EP0148431A1 (de) | 1985-07-17 |
| AU3704284A (en) | 1985-07-04 |
| FI845084A0 (fi) | 1984-12-21 |
| FI845084L (fi) | 1985-06-24 |
| HUT37763A (en) | 1986-02-28 |
| ES8601913A1 (es) | 1985-11-16 |
| ES8604162A1 (es) | 1986-01-16 |
| HU193073B (en) | 1987-08-28 |
| ES544119A0 (es) | 1986-01-16 |
| ES544116A0 (es) | 1986-01-16 |
| ES538929A0 (es) | 1985-11-16 |
| DK597484D0 (da) | 1984-12-13 |
| ES544117A0 (es) | 1986-01-16 |
| JPS60156676A (ja) | 1985-08-16 |
| ES8604163A1 (es) | 1986-01-16 |
| DD232697A5 (de) | 1986-02-05 |
| ES544118A0 (es) | 1986-01-16 |
| ES8604164A1 (es) | 1986-01-16 |
| ES8604165A1 (es) | 1986-01-16 |
| ZA849972B (en) | 1986-08-27 |
| IL73897A0 (en) | 1985-03-31 |
| DE3346575A1 (de) | 1985-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4582837A (en) | Imidazo[4,5-b] and [4,5-c]pyridine derivatives having cardiotonic activity | |
| FI66372C (fi) | Foerfarande foer framstaellning av farmakologiskt verkande i 5- eller 6-staellning med en pyridazinonring substituerade besimidazoler | |
| NO862477L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| GB2163747A (en) | Benzimidazole derivatives | |
| NO814239L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinon-derivater | |
| US4698344A (en) | 1-Heteroaryl-4-aryl-pyrazolin-5-ones for use as medicaments | |
| NO874153L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
| EP0070518A2 (en) | Imidazoquinoxaline compounds | |
| HU198060B (en) | Process for producing new thienopyridinones and pharmaceutical compositions comprising same | |
| NO842684L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater | |
| NO845169L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater | |
| NO139386B (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive imidazopyridiner | |
| US5212186A (en) | Cardioactive pyrrolobenzimidazoles | |
| US3176017A (en) | Aroylalkyl derivatives of diazabicyclo-nonanes and-decanes | |
| US4267343A (en) | Process for the manufacture of 2,5-bis-(benzoxazolyl)-thiophene compounds | |
| NO149314B (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner | |
| EP0354788A1 (en) | Novel imidazole derivatives | |
| NO158738B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazin-2-on-derivater. | |
| NO845170L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| EP0207483B1 (de) | Neue Benzimidazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel sowie Zwischenprodukte | |
| Huckle et al. | 4-Amino-2, 3, 4, 5-tetrahydro-1-benzoxepin-5-ols, 4-amino-2, 3, 4, 5-tetrahydro-1-benzothiepin-5-ols, and related compounds | |
| EP0412529B1 (en) | Imidazole derivatives, process for the preparation of the same and antiulcer agents containing the same | |
| NO874780L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| US4588723A (en) | Aminoalkyl-imidazothiadiazole-alkenecarboxylic acid amides, intermediates for their preparation and their use in medicaments | |
| NZ201363A (en) | Sulphimine derivatives,and pharmaceutical compositions containing such |